In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in Medicare Part D and more detailed reporting to plan sponsors.But this is only the tip of the iceberg when it comes to the PBM reform that advocates are calling for. Many would like to see Congress address vertical integration with insurers and pharmacies. The three biggest PBMs are owned by large insuranc...
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.